ICD-10-CM Billable Code

M30.1

Polyarteritis with lung involvement [Churg-Strauss]

Clinical Classification Guidelines

Inclusion Terms

  • Allergic granulomatous angiitis
  • Eosinophilic granulomatosis with polyangiitis [EGPA]

Medical Intelligence & Overview

Polyarteritis with lung involvement, also known as Churg-Strauss syndrome or eosinophilic granulomatosis with polyangiitis (EGPA), is a rare autoimmune condition characterized by inflammation of small to medium-sized blood vessels. This inflammation can restrict blood flow and damage tissues and organs, most notably affecting the lungs, skin, nerves, and sinuses. The condition typically develops in individuals with a history of asthma or allergies and progresses through various stages including allergic, eosinophilic, and vasculitic phases.

Causes & Symptoms

Clinical Causes: The exact cause of Churg-Strauss syndrome is unknown, but it is believed to involve an abnormal immune response. It is associated with a higher presence of eosinophils, a type of white blood cell involved in allergic reactions and fighting parasitic infections. Genetic factors may contribute, though specific genes are not well-identified. Environmental exposures, such as allergens or infections, may trigger the condition in susceptible individuals.

Key Symptoms: Asthma, often worsening or unusual in pattern. Allergic symptoms including runny nose, nasal polyps, and sinus inflammation. Skin rashes or nodules. Peripheral neuropathy, leading to numbness or tingling in hands and feet. Fever and fatigue. Weight loss and malaise. Eosinophilia – an increased number of eosinophils in blood tests. Lung involvement may cause cough, shortness of breath, or chest pain. Other organ symptoms depending on the extent of blood vessel inflammation.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, blood tests, and tissue biopsies. Key steps include: - Blood tests showing eosinophilia and inflammatory markers. - Imaging studies such as chest X-rays or CT scans to assess lung involvement. - Biopsy of affected tissue to reveal eosinophilic infiltration and vasculitis. - Exclusion of other causes of eosinophilia, such as parasitic infections or allergies. - Monitoring for signs of organ involvement to guide treatment.

Treatment Protocols: Treatment aims to reduce inflammation and suppress the immune response. Typical approaches include: - Corticosteroids, such as prednisone, to control inflammation. - Immunosuppressive drugs like cyclophosphamide or azathioprine for severe cases. - Monitoring eosinophil levels and organ function. - Managing asthma and allergy symptoms effectively. - In some cases, biologic therapies targeting specific immune pathways are considered. - Regular follow-up to monitor disease activity, medication side effects, and organ health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M30.1 a billable ICD-10 code?
Yes, M30.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M30.1?
Clinical documentation must specify the nature of Polyarteritis with lung involvement [Churg-Strauss] and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

polyarteritis involvement